People receiving AI-supported screening for diabetic retinopathy, a leading cause of blindness globally, were almost twice as likely to attend specialist follow-up appointments as those receiving standard screening, according to new research from the London School of Hygiene & Tropical Medicine (LSHTM).
AI Screening Increases Attendance for Diabetic Eye Care Follow-ups
Research from the London School of Hygiene & Tropical Medicine indicates that AI-supported screening for diabetic retinopathy significantly increases attendance at follow-up appointments compared to standard screening. This advancement could enhance healthcare access for diabetic patients in Iran, where eye care services are critical due to rising diabetes rates. Improved eye care access is essential for preventing blindness in the population.
👥 Key Players
📰 What Happened
New research shows that AI-supported screening for diabetic retinopathy significantly increases the likelihood of patients attending follow-up appointments compared to standard methods. This finding suggests a potential improvement in diabetic eye care management.
- AI-supported screening nearly doubles attendance at follow-up appointments.
- Diabetic retinopathy is a leading cause of blindness globally.
💡 Why It Matters
📚 Background
Diabetic retinopathy is a common complication of diabetes that can lead to blindness if not managed properly. Access to timely follow-up care is critical for prevention.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%